1. Vapi gelatine capacity expansion - The board approved a ₹80 Cr upgrade of the Vapi plant to lift gelatine capacity from 2,000 MT to 2,700 MT, with completion targeted within 1.5 years from November 2025. This adds 35% more volume to a line already running above 90% utilisation, directly relieving the company's tightest physical constraint on revenue.
2. Solar power and energy cost reduction - A solar power plant commissioned in FY25 has already cut power costs by 5%, and the company is studying further renewable-energy and efficiency measures across the boiler, hot-water generation, and effluent treatment. Sustained energy savings flow straight to operating margin in a business where power is a meaningful input cost.
3. Imported raw-material sourcing - Successful trials of imported gel bones from new regions are reducing dependence on suboptimal domestic raw materials and lifting yield and quality. Better input quality supports both premium product positioning and higher plant throughput.
4. New gelatine grades and premium positioning - The company is developing processes for new grades of gelatine and expects strategic cost efficiencies and premium product positioning to strengthen margins in FY26. Moving up the grade ladder raises the realisation per tonne without requiring additional base capacity.
5. Waste-to-revenue valorisation - Feasibility studies are underway for equipment that generates revenue from waste and for using waste products as raw-material inputs for other industries. Converting a cost centre into a revenue stream would improve both margins and asset turns.
6. Nutraceutical vertical - Everpure Life marine collagen - The company is building a presence in nutraceuticals through its Everpure Life marine collagen brand and sees opportunity in collagen peptides and marine-based gelatine for halal, kosher, and premium markets. This opens a consumer-facing, higher-margin channel beyond the core industrial gelatine business.